These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21188016)

  • 21. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated digital image analysis (TrichoScan) in male patients with androgenetic alopecia; comparison with manual marking of hairs on trichoscopic images.
    Bilgiç Temel A; Gülkesen KH; Dicle Ö
    Skin Res Technol; 2018 Aug; 24(3):515-516. PubMed ID: 29363174
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Hair Restoration Technology Counteracts Androgenic Hair Loss and Promotes Hair Growth in A Blinded Clinical Trial.
    Thor D; Pagani A; Bukowiecki J; Houschyar KS; Kølle ST; Wyles SP; Duscher D
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular density and ratios in scarring and nonscarring alopecia.
    Horenstein MG; Bacheler CJ
    Am J Dermatopathol; 2013 Dec; 35(8):818-26. PubMed ID: 23435361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of female pattern hair loss: a study in a Turkish population.
    Aktan S; Akarsu S; Ilknur T; Demirtaşoğlu M; Ozkan S
    Eur J Dermatol; 2007; 17(4):321-4. PubMed ID: 17540640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia.
    Ruiz RG; Rosell JMC; Ceccarelli G; De Sio C; De Angelis GC; Pinto H; Astarita C; Graziano A
    J Cell Physiol; 2020 May; 235(5):4587-4593. PubMed ID: 31643084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
    Whiting DA
    J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods of hair loss evaluation in patients with endocrine disorders.
    Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L
    Endokrynol Pol; 2010; 61(4):406-11. PubMed ID: 20806187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Term Efficacy of Autologous Cellular Micrografts in Male and Female Androgenetic Alopecia: A Retrospective Cohort Study.
    Zari S
    Clin Cosmet Investig Dermatol; 2021; 14():1725-1736. PubMed ID: 34824538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body hair counts during hair length reduction procedures: a comparative study between Computer Assisted Image Analysis after Manual Processing (CAIAMP) and Trichoscan(™).
    Van Neste DJ
    Skin Res Technol; 2015 Aug; 21(3):373-9. PubMed ID: 25639154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of hair follicle parameters using TrichoScale Pro
    Schuldenfrei MD; Pieper JB
    Vet Dermatol; 2020 Jun; 31(3):181-e37. PubMed ID: 31898370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of male pattern alopecia with platelet-rich plasma: A double-blind controlled study with analysis of platelet number and growth factor levels.
    Rodrigues BL; Montalvão SAL; Cancela RBB; Silva FAR; Urban A; Huber SC; Júnior JLRC; Lana JFSD; Annichinno-Bizzacchi JM
    J Am Acad Dermatol; 2019 Mar; 80(3):694-700. PubMed ID: 30287324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods of evaluating hair growth.
    Chamberlain AJ; Dawber RP
    Australas J Dermatol; 2003 Feb; 44(1):10-8. PubMed ID: 12581076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-rich plasma on female androgenetic alopecia: Tested on 10 patients.
    Starace M; Alessandrini A; D'Acunto C; Melandri D; Bruni F; Patrizi A; Piraccini BM
    J Cosmet Dermatol; 2019 Feb; 18(1):59-64. PubMed ID: 29707872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of hair follicle parameters using computer image analysis: a comparison of androgenetic alopecia with normal scalp biopsies.
    Lee MS; Kossard S; Wilkinson B; Doyle JA
    Australas J Dermatol; 1995 Aug; 36(3):143-7. PubMed ID: 7487740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular miniaturization in female pattern hair loss: clinicopathological correlations.
    Messenger AG; Sinclair R
    Br J Dermatol; 2006 Nov; 155(5):926-30. PubMed ID: 17034520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.